This inventor holds 1 USPTO granted patent. Top assignees: Emory University, University of Illinois. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,024 
1 out of 2,432 
Years Active: 2018
Title: **Innovative Contributions of Inventor Sang Ho Lee**
Introduction
Sang Ho Lee, an accomplished inventor based in Decatur, Georgia, has made significant strides in the field of biomedical research. His innovative work primarily focuses on transforming fibroblasts into endothelial and endothelial-like cells, which could have far-reaching implications in medicine.
Latest Patents
Sang Ho Lee holds a patent titled "Endothelial and endothelial-like cells produced from fibroblasts and uses related thereto." This groundbreaking patent discloses a method for culturing endothelial or endothelial-like cells derived from fibroblasts exposed to the transcription factor ETV2. The process involves exposing fibroblasts to ETV2 under specific conditions, resulting in a pool of cells that express increased levels of endothelium surface markers. These endothelial-like cells have potential applications in the treatment of various conditions, including vascular issues, cardiac health, and wound healing.
Career Highlights
Sang Ho Lee's career is marked by his impactful research and contributions to the scientific community. He has worked at reputable institutions such as Emory University and the University of Illinois, where he has been instrumental in advancing the understanding of cell differentiation and regenerative medicine. His innovative methods are set to pave the way for new therapeutic approaches in treating vascular and cardiac diseases.
Collaborations
Throughout his career, Sang Ho Lee has had the opportunity to collaborate with notable peers, including Young-Sup Yoon and JiWoong Han. These collaborations have enhanced his research capabilities and expanded the potential applications of his patents in clinical settings.
Conclusion
Sang Ho Lee's pioneering work in producing endothelial-like cells from fibroblasts represents a significant advancement in biomedical research. His contributions not only enhance our understanding of cell biology but also offer promising therapeutic avenues for treating critical health conditions. As he continues to innovate, Sang Ho Lee stands out as a leading figure in the field of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile